<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-vaccines-07-00074">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gilbert</surname>
    <given-names>P.B.</given-names>
   </name>
   <name>
    <surname>Juraska</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>DeCamp</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Karuna</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Edupuganti</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mgodi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Donnell</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Bentley</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sista</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Andrew</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials</article-title>
  <source>Stat. Commun. Infect. Dis.</source>
  <year>2017</year>
  <volume>9</volume>
  <fpage>20160001</fpage>
  <pub-id pub-id-type="doi">10.1515/scid-2016-0001</pub-id>
  <?supplied-pmid 29218117?>
  <pub-id pub-id-type="pmid">29218117</pub-id>
 </element-citation>
</ref>
